Total Live Articles: 421

Inflammatory Eye Disease (Uveitis, Scleritis, Episcleritis)

NICE CKS Uveitis. Last revised: Mar 2025.

NICE CKS Red eye. Last revised: Mar 2026.

Inflammatory Eye Disease (Uveitis, Scleritis, Episcleritis)

Inflammatory eye disease includes important causes of red eye, such as anterior uveitis, scleritis, and episcleritis. Anterior uveitis and scleritis can be sight-threatening and usually require same-day ophthalmology assessment, while episcleritis is usually benign and self-limiting.

This updated UKMLA guide covers anterior uveitis, scleritis and episcleritis: causes, risk factors, symptoms, diagnosis, complications, and management.

High-Yield Comparison Table

Feature Anterior uveitis Scleritis Episcleritis
Affected structure Iris and ciliary body Sclera (the deep, main wall of the eye) Episclera (superficial to the sclera)
Pain Present Present, especially on eye movement Mild discomfort
Photophobia Present May be present Absent
Eye appearance Ciliary injection around the cornea Deep red / violaceous Localised / sectoral redness
Vision Affected Normal
Pupil May be small or irregular Normal
Urgency Same-day ophthalmology referral Non-urgent

Uveitis

Uveitis is inflammation of the uvea, the pigmented middle layer of the eye, which includes the iris, ciliary body and choroid.

The most common type is anterior uveitis, which primarily affects the iris and anterior ciliary body. It is also referred to as iritis, iridocyclitis, and anterior cyclitis.

Other types include:

  • Intermediate uveitis: primarily involves the anterior vitreous, ciliary body, and peripheral retina
  • Posterior uveitis (least common): affects the choroid +/- retina and optic nerve

For this article, the focus is on anterior uveitis, as this is the most common and most relevant form at a non-specialist / UKMLA level.

Causes and Risk Factors

Anterior uveitis may be idiopathic or associated with an underlying cause:

Category Causes
Systemic autoimmune disorder (most important)
  • HLA-B27 associated disorders
    • Ankylosing spondylitis
    • Reactive arthritis
    • Psoriatic arthritis
    • Enteropathic arthritis
  • Juvenile idiopathic arthritis
  • Behcet’s disease
  • Sarcoidosis
  • Multiple sclerosis
Infection
  • Viral (e.g. HSV, VZV, CMV, HIV)
  • Bacterial (e.g. tuberculosis, syphilis, Lyme disease)
  • Parasitic (toxoplasmosis – most common cause of posterior uveitis)
  • Fungal (e.g. histoplasmosis, candidiasis)
Other causes
  • Use of certain medications (e.g. rifabutin, bisphosphonates)
  • Eye trauma / surgery (can trigger inflammatory responses)

Risk factors:

  • Previous uveitis
  • Personal or family history of autoimmune disorders
  • Smoking
  • HLA-B27 +ve
    • ~50% of patients with acute uveitis are HLA B27 +ve
    • However, the lifetime risk of developing acute anterior uveitis in HLA-B27 +ve individuals is only 1%

Clinical Features

Acute anterior uveitis typically presents as unilateral (bilateral also possible):

  • Red, painful eye
    • Dull / ache pain
    • Pain is worse on induced pupil constriction
  • Blurred visionreduced visual acuity
  • Photophobia
  • Epiphora (watery eyes)

Signs:

  • Changes to pupil
    • Small / constricted pupil
    • Irregular pupil
  • Ciliary injection around the cornea
  • Hypopyon – usually only seen in severe anterior uveitis

The following is normal in anterior uveitis:

  • Corneal fluorescein staining
  • No discharge
  • Extra-ocular movement
  • IOP (can be transiently elevated)
  • Eyelid, lashes and lacrimal ducts
  • Lens (unless there is concurrent cataract)

Intermediate and posterior uveitis may present more with floaters, blurred vision or reduced vision, rather than the classic painful photophobic red eye of anterior uveitis.

Complications

Uveitis can be sight-threatening, particularly if recurrent, severe, chronic, or inadequately treated

  • Uveitis is implicated in up to 25% of cases of legal blindness in the developing world
  • Major causes of vision loss are cystoid macular oedema, secondary cataracts, and secondary glaucoma

Uveitis in the paediatric population (e.g. in JIA) is more likely to be chronic and has higher risk of complication and visual impairment.

~1/3 of children with uveitis suffer severe visual loss.

Investigation and Diagnosis

All suspected cases of uveitis should be referred urgently to ophthalmology (same-day) for diagnosis and management.

Perform the following assessment:

  • Visual acuity assessment (Snellen chart)
  • IOP measurement (to exclude glaucoma)
  • Corneal fluorescein staining (to exclude corneal superficial injury)

Definitive test: slit lamp examination showing:

  • Presence of WBCs in the anterior chamber aqueous humour
  • Hazy aqueous humour due to protein leakage

Management

All suspected cases of uveitis should be referred urgently to ophthalmology (same-day) for diagnosis and management.

Do not initiate treatment in primary care unless instructed by an ophthalmologist.

Secondary care treatment depends on the underlying cause:

Uveitis cause Management
Non-infective uveitis Standard treatment:

  • Topical corticosteroids (e.g. dexamethasone, prednisolone), PLUS
  • Topical cycloplegic mydriatic drug (e.g. cyclopentolate, atropine eye drops)

NICE CKS notes that corticosteroids may be given by several routes, including topical, oral, intravenous, intramuscular, periocular, intraocular injection, or implant.

For non-specialist level, the key point is that uncomplicated anterior uveitis is usually managed with topical corticosteroids under ophthalmology supervision.

Severe or chronic cases may be treated with:

  • Systemic immunosuppressants (e.g. corticosteroids, methotrexate, mycophenolate, TNF inhibitors)
  • Laser phototherapy
  • Cryotherapy
  • Vitrectomy
Infective uveitis Appropriate anti-microbial drugs should be given in addition to corticosteroids and cycloplegics

Scleritis

Scleritis refer to the inflammation of the sclera – the white outer wall of the eye

Causes and Risk Factors

~50% cases have an underlying autoimmune condition [Ref]

  • Rheumatoid arthritis – most common
  • Systemic vasculitis (e.g. giant cell arteritis, GPA)
  • SLE
  • Sarcoidosis

Infections account for 4-10% of scleritis cases [Ref]

Clinical Features and Diagnosis

Typical presentation:

  • Red, painful eye with deep red / dark / violaceous scleral redness
  • Severe, deep eye pain (often described as dull / boring / aching pain)
    • Pain is worse with eye movement
    • Can be severe enough to wake the patient from sleep
  • Tenderness of the globe
  • Visual blurring and photophobia may occur but are less prominent

The following is normal in scleritis:

  • Corneal fluorescein staining
  • No discharge
  • Extra-ocular movement (apart from pain)
  • IOP
  • Eyelid, lashes and lacrimal ducts
  • Lens (unless there is concurrent cataract)

Complications

Scleritis can threaten vision

It may lead to serious complications such as scleral thinning and subsequent globe perforation

Investigation and Diagnosis

All suspected cases of scleritis should be referred urgently to ophthalmology (same-day) for diagnosis and management.

Gold standard: slit-lamp examination

Topical phenylephrine drops can be applied to distinguish between scleritis and episcleritis

  • In scleritis: vessels will NOT blanch
  • In episcleritis: vessels will blanch (turn white)

Click to see rationale.

Other investigations are often necessary: [Ref]

  • Imaging (e.g. B-scan ultrasound, CT/MRI) to assess the extent of inflammation, visualise necrosis and diagnose posterior scleritis
  • A work-up for the underlying cause is necessary (e.g. autoimmune and vasculitis markers, inflammatory markers, infectious disease screening)
  • Chest X-ray (to exclude sarcoidosis)

Scleritis vs episcleritis

  • Clinical features
    • Scleritis: red, painful eye that is worse on eye movement +/- affected vision and photophobia
    • Episcleritis: red eye with mild discomfort + normal vision
  • Vessels
    • Deep vessels affected in scleritis and not mobile
    • Superficial vessels affected in episcleritis and may be mobile
  • Application of phenylephrine
    • Vessels do NOT blanch in scleritis
    • Vessels blanch in episcleritis
    • Click to see rationale

Management

All suspected cases of scleritis should be referred urgently to ophthalmology (same-day) for diagnosis and management.

Typical 1st line management involves oral NSAIDs (e.g. ibuprofen, naproxen, indomethacin) [Ref]

Other further treatment: [Ref]

  • Systemic corticosteroids
  • Subconjunctival corticosteroid injections
  • Immunosuppressive agents (e.g. methotrexate)
  • Biologics

Episcleritis

Episcleritis is a benign inflammatory condition of the episclera – the superficial vascular layer between the conjunctiva and the sclera.

Causes and Risk Factors

Most cases are idiopathic [Ref]

Some cases are driven by an underlying systemic disorder: [Ref]

  • Rheumatoid arthritis
  • SLE
  • Psoriatic arthritis and reactive arthritis
  • Ankylosing spondylitis
  • IBD

Patients with acute episcleritis often have coexisting ocular surface diseases: [Ref]

  • Ocular rosacea – most common
  • Dry eye
  • Atopic keratoconjunctivitis

Clinical Features and Diagnosis

Acute onset of unilateral: [Ref]

  • Red eye (segmental redness)
  • Generally painless
    • Mild localised discomfort or pain is possible
    • No pain on eye movements
  • Lacrimation

The following are typically normal: [Ref]

  • Vision (photophobia is uncommon)
  • Pupil
  • Eye movement
  • No discharge
  • Normal corneal fluorescein staining

Scleritis vs episcleritis

  • Clinical features
    • Scleritis: red, painful eye that is worse on eye movement +/- affected vision and photophobia
    • Episcleritis: red eye with mild discomfort + normal vision
  • Vessels
    • Deep vessels affected in scleritis and not mobile
    • Superficial vessels affected in episcleritis and may be mobile
  • Application of phenylephrine
    • Vessels do NOT blanch in scleritis
    • Vessels blanch in episcleritis
    • Click to see rationale

Management

Unlike anterior uveitis and scleritis, which require urgent referral within 24 hours, episcleritis does not require urgent referral and can usually be managed in primary care.

Reassure the person that episcleritis is usually self-limiting and is not harmful.

If symptomatic, consider:

  • Cold compress
  • Artificial tears
  • If there is more severe inflammation, consider topical NSAIDs or corticosteroids

References

Related Articles

Red Eye Referral

Allergic Conjunctivitis

Infective Conjunctivitis

Infective Keratitis

Acute Angle-Closure Glaucoma

Periorbital and Orbital Cellulitis

Benign Eyelid Disorders

Rheumatoid Arthritis (RA)

Systemic Lupus Erythematosus (SLE)

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.